ZYBT

Zhengye Biotechnology Holding
ZYBT

8 hedge funds and large institutions have $113K invested in Zhengye Biotechnology Holding in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.53K
2
+$793

Top Sellers

1
-$39.9K
2
-$35.2K
3
-$28K
4
XT
XTX Topco
Cayman Islands
-$14.2K
5
Morgan Stanley
Morgan Stanley
New York
-$1.26K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
1
XTX Topco
Cayman Islands
$41.3K
WG
2
Winton Group
United Kingdom
$31.2K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$27.2K
UBS Group
4
UBS Group
Switzerland
$7.51K
TRCT
5
Tower Research Capital (TRC)
New York
$4.59K
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$1K
Morgan Stanley
7
Morgan Stanley
New York
$244
CIAM
8
Caitong International Asset Management
Hong Kong
$1
Invesco
9
Invesco
Georgia
–
Citadel Advisors
10
Citadel Advisors
Florida
–
JP Morgan Chase
11
JP Morgan Chase
New York
–